Biosimilars & Biologics

The development of biosimilars and innovative biologics demands precision, deep scientific insight, and a highly customized approach. At Triumpharma, we partner closely with you to design and execute tailored clinical strategies that align perfectly with your specific therapeutic indications and study goals.

We ensure patient safety and data integrity at every critical milestone, offering end-to-end capabilities that support your trial from inception to marketing authorization in Europe and other global markets.

Specific Services & Capabilities:

• Customized trial planning and execution strategies (Phase I-III)
• Targeted subject and patient recruitment
• Stringent clinical safety monitoring
• Specialized pharmacy support and management
• Dedicated bioanalytical support for complex large molecules
• Expertise in hormones, monoclonal antibodies and protein-derived molecules (e.g., WAIHA, HAE, Rheumatoid Arthritis)